跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mesothelin
首页
药物
Mesothelin
Mesothelin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
EP 3083964 B1
申请人: NOVARTIS AG
优先权: 2013
CN
EP
US
WO
12 件公开
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
EP 3151854 B1
申请人: MEMORIAL SLOAN KETTERING CANCER CENTER
优先权: 2014
CN
EP
US
WO
12 件公开
Anti-mesothelin antibodies
US 7592426 B2
申请人: MORPHOTEK INC
优先权: 2006
US
11 件公开
US 12325742 B2
申请人: INVOX PHARMA LTD
优先权: 2018
CN
EP
US
WO
6 件公开
EP 4554980 A4
申请人: NONA BIOSCIENCES SUZHOU CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
US 8460660 B2
申请人: HO MITCHELL
优先权: 2010
US
2 件公开
WO 2025247171 A1
申请人: HARBOUR ANTIBODIES BV
优先权: 2024
WO
Human antibodies that bind mesothelin, and uses thereof
US 8268970 B2
申请人: TERRETT JONATHAN A
优先权: 2008
US
9 件公开
CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS
EP 3707160 A1
申请人: THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
优先权: 2017
CN
EP
US
WO
7 件公开
Anti-mesothelin antibodies and immunoconjugates
US 8911732 B2
申请人: DENNIS MARK
优先权: 2010
CN
US
7 件公开
Mesothelin and CD137 binding molecules
US 12319739 B2
申请人: F STAR DELTA LTD
优先权: 2018
CN
EP
US
WO
5 件公开
Anti-mesothelin chimeric antigen receptor specifically binding to mesothelin
US 11795215 B2
申请人: CELLENGENE INC
优先权: 2020
CN
EP
US
WO
5 件公开
HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
EP 4149632 A1
申请人: XENCOR INC
优先权: 2020
EP
US
WO
5 件公开
COMPOSITIONS AND METHODS FOR TREATING MESOTHELIN POSITIVE CANCERS
EP 4100028 A4
申请人: A2 BIOTHERAPEUTICS INC
优先权: 2020
EP
US
WO
5 件公开
US 20250269027 A1
申请人: A2 BIOTHERAPEUTICS INC
优先权: 2022
CN
US
2 件公开
第 1 / 9 页
上一页
下一页
药物
反馈